SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-20-019141
Filing Date
2020-09-01
Accepted
2020-09-01 17:41:25
Documents
1
Period of Report
2020-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 4208
  Complete submission text file 0001437749-20-019141.txt   5699
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Issuer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 VISTA BLVD, #305 WACONIA MN 55387
Business Address
Cullen Michael T. (Reporting) CIK: 0001652996 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39468 | Film No.: 201155219